Bionovo Announces $5M Financing PharmaceuticalOnline Wed, 04 Jan 2012 01:51 AM PST Bionovo, Inc. (NASDAQ: BNVI), a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced that it has entered into a $5 million securities purchase agreement with Socius CG II, Ltd. ("Socius"), a Bermuda-based subsidiary of Socius Capital Group, LLC. | Argentine leader set for surgery BBC News Wed, 04 Jan 2012 01:50 AM PST Supporters of Argentina's President Cristina Fernandez gather outside the hospital where she is due to have surgery for thyroid cancer. | 'Jordan records 13 cancer cases daily' MENAFN Wed, 04 Jan 2012 01:22 AM PST (MENAFN - Jordan Times) The Kingdom registers around 13 cancer cases every day, while breast cancer is the most common form of the disease, a Ministry of Health official said on Tuesday. Mohammad ... | Video: 'Where's Wallace' charity challenge Cambridge Evening News Wed, 04 Jan 2012 01:02 AM PST A dedicated fundraiser who gave up his job and his home on his 30th birthday to embark upon a charity quest kicked off the new year in Cambridge. Matt Wallace visited researchers at the Cancer Research UK Cambridge Institute at Addenbrookeâs yesterday. | Exercise cuts bowel cancer risk, shows study New Kerala Wed, 04 Jan 2012 00:57 AM PST Sydney, Jan 4 : People who are most physically active have a lower risk of bowel cancer than the least active, according to an Australian study. | FDA To Review Potential New Use Of XGEVA® (Denosumab) At Oncologic Drugs Advisory Committee Meeting PharmaceuticalOnline Wed, 04 Jan 2012 00:51 AM PST Amgen (NASDAQ: AMGN) today announced the U.S. Food and Drug Administration (FDA) has invited the Company to participate in a meeting of the Oncologic Drugs Advisory Committee (ODAC) on Feb. 8, 2012 to discuss the supplemental Biologics License Application (sBLA) for XGEVA® (denosumab) to treat men with castration-resistant prostate cancer (CRPC) at high risk of developing bone metastases. | | |
|